A major cause of treatment failure in patients with acute myeloid leukemia (AML) is the occurrence of resistance to structurally and functionally unrelated drugs, called multidrug resistance (MDR).

Glucagon-like peptide (GLP)-1 and the synthetic analogue exenatide: From novel therapy for diabetes to growth inhibition of breast cancer cells. Background: Gene expression signatures have highlighted ...

9q32-q33.1 amplification as a prognostic factor for overall survival in metastatic germ cell tumors. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not ...